The Complementary Roles of Imaging and ‘Omics’ for Future Anti-Atherosclerotic Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|33|5963-5971

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5963-5971

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5909-5928

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1103-1106

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium antagonists as anti-atherosclerotic agents

By Gaviraghi G.   Trist D.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 135-146

Informa Healthcare

Access to resources Recommend Favorite

New Trends in Anti-Atherosclerotic Agents

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1755-1772

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the role of microRNAs in lipid metabolism-related anti-atherosclerotic drug discovery

By Wang Li   Yang Yuan   Hong Bin  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 977-990

Informa Healthcare

Access to resources Recommend Favorite